After settling down comfortably into my seat on a flight from Chicago to San Francisco, I started browsing through my digital copy of the latest issue of The Economist. Much to my surprise, I saw an article titled, The Usefulness of Managers beginning with the sentence, "Is your manager really necessary?" Bingo!!! My mind went back to so many discussions we keep having about our Indian Pharma industry and the various arguments about line management and their contributions, role clarity, their usefulness and the often-asked question, “Are they really effective?” When the top leadership says, that effective managers are a rare breed with comments such as, “they are the weakest link in our chain”, my mind keeps racing through with the thought as to, “if they are not, who has to be responsible to make them effective?” Having been a line manager and climbing the ladder against odds, I can understand and empathise with both sides of this management world. However, when these doubts and questions keep raising its head often, my curiosity quotient kept raising a question, “Are we in Indian pharma very unique to have such challenges?” A chance meeting I had with a team of Google senior management personnel based in Google’s headquarters in California during this trip gave me an interesting insight on what Google did and what it continues to do. Much to my solace I found that their apprehensions were similar to what we in Indian Pharma face. The differentiating factor was that their "people operations" team (HR) has applied the Google Way (data analytics) to management analysis and developed a manifesto entitled Eight Habits of Highly Effective Google Managers.

The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.

DigiStorm 2018 was held on 11 September at the Lalit Ashok in Bangalore. The event was headlined by Prabir Jha – President & Global Chief People Officer, Cipla. Deep Bhandari – Editorial Board Member, MedicinMan, gives us the highlights of the post-lunch session.

As an MNC Head, I was one among the...

Who we are, What we think and How we do

Roots Analysis recently published a report on the global Power...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

How a niche Indian topicals manufacturer outgrew its CDMO...

Roots Analysis recently published a report on the global Power...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

How a niche Indian topicals manufacturer outgrew its CDMO...

Roots Analysis recently published a report on the global Power...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

How a niche Indian topicals manufacturer outgrew its CDMO...

Roots Analysis recently published a report on the global Power...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

How a niche Indian topicals manufacturer outgrew its CDMO...